Deal Library / Pharma BD Deal Intelligence

SK Biopharmaceuticals Co., Ltd. — Pharma Deals

The Pharma Closeout tracks 3 deals, $3.6B in disclosed deal value, 1 with a post-close Outcome Score for SK Biopharmaceuticals Co., Ltd..

Median Critic Score: 75  ·  Median Outcome Score: 48

All 3 deals

• SK Biopharmaceuticals Co., Ltd. / Insilico Medicine Inc. — 2026 · $2.5B · Mixed — partial payoff, real shortfalls.
• SK Biopharmaceuticals Co., Ltd. / 1ST Biotherapeutics, Inc. — 2026 · $315M
• SK Biopharmaceuticals Co., Ltd. / Biohaven Pharmaceutical Holding Company Ltd. — 2026 · $795M

← Deal Library  ·  Interactive search  ·  How we score deals